Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid fell by as much as 20% in pre-market trading on Thursday, after the company said its full-year results would be undermined by declining numbers of people falling sick with colds and coughs. The retail drugstore industry has been hit by a weak sales season, due to measures to curtail the spread of coronavirus, the company said. As a result of physical distancing, face masks, and use of sanitizers, Rite Aid said it saw a decline of nearly 37% in its cough, cold, and flu-related product categories.

Rite Aid plunges 20% after cutting its full-year forecast as the drugstore chain saw fewer people getting colds and coughs

Rite Aid warned of a soft cold and flu season that's going to hit the company's bottom line worse than expected for its fiscal 2021.

Rite Aid: ‘Soft Cough, Cold And Flu Season' Triggers Bigger Annual Loss Than Expected

Shares of Rite Aid Corp. fell more than 18% in the extended session Wednesday after the drugstore chain lowered its guidance for fiscal 2021, saying its bottom line was "significantly" hampered by a "soft" cold and flu season, the ongoing pandemic, and "challenging" weather. Same-store sales fell about 5.6% in the quarter ended in February, mostly due to a decline of nearly 37% percent in cough, cold and flu-related categories, the company said.

Rite Aid stock down 18% after lower 2021 guidance on 'soft' flu season

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation's (NYSE: RAD) fourth quarter 2021 financial results were significantly impacted by a soft cough, cold and flu season, ongoing impacts related to COVID-19 and challenging weather conditions. As a result, the Company is updating its guidance for the fiscal year ended February 27, 2021. “During the fourth quarter our industry was impacted by a historically soft cough, cold and flu season, as well as the continued impacts of COVID on the deferra

Rite Aid Provides Update on Fiscal Year 2021 Guidance

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid today announced it has extended the priority COVID-19 vaccine scheduling period for teachers, school staff and childcare providers, in accordance with a directive from the United States Department of Health and Human Services (HHS) and the Biden Administration, to ensure these groups are vaccinated during the month of March. Continuing last week's initiative, the scheduling of select COVID-19 vaccine appointments at Rite Aid will be available exclusivel

Rite Aid Extends COVID-19 Vaccine Priority Scheduling Period for Teachers, School Staff and Childcare Providers

Rite Aid has a growing retail pharmacy business generating over $15 billion in annual revenues. RAD owns a Prescription Benefits Management (PBM) service, now known as Elixir, currently generating an additional $8 billion in annual revenues.

Rite Aid, No Matter How You Cut It, It Is The Right Stock

Penn Entertainment

CleanSpark

CrowdStrike

Penn National Gaming, CrowdStrike, Rite Aid and CleanSpark were our top stock trades for Wednesday. Now, let's get a look at the charts.

4 Top Stock Trades for Wednesday: PENN, CRWD, RAD, CLSK

CAMP HILL, Pa.--(BUSINESS WIRE)--In accordance with a directive from the United States Department of Health and Human Services (HHS) and the Biden Administration, Rite Aid today announced expanded eligibility for COVID-19 vaccine appointments to pre-K to high school educators, school staff and licensed childcare program staff. To comply with the HHS directive to ensure teachers, school staff and childcare workers are vaccinated during the month of March, select COVID-19 vaccine appointments at

Rite Aid Expands and Prioritizes COVID-19 Vaccine Eligibility to Teachers, School Staff and Childcare Providers

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced expanded commitments to reduce toxic chemicals in the products it sells, doubling down on its efforts to ensure clean, safe product ingredients as part of the company's RxEvolution strategy. Rite Aid's commitment to improve chemical management and product safety directly aligns with the company's objective to help customers achieve whole health. Following an evaluation of current practices, Rite Aid has identified several new

Rite Aid Expands Commitment to Improving Chemical Management and Product Safety

Rite Aid Corp. said Thursday that as part of the Federal Retail Pharmacy Program, which launches Thursday, that will receive COVID-19 vaccines directly from the U.S. government in five states and two major cities. Participating stores in California, Michigan, New Jersey, Ohio and Pennsylvania, as well as New York City and Philadelphia, will receive 100 doses per week, with allocations to grow over time.

Rite Aid stores to receive 100 COVID-19 vaccines a week in 5 states and New York City, Philadelphia

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is expanding no-charge COVID-19 self-swab testing to all drive-through locations, with 441 additional sites opening Friday, February 12, through its partnership with the U.S. Department of Health and Human Services (HHS). The new testing sites will increase Rite Aid's capacity for COVID-19 testing services in California, Connecticut, Delaware, Idaho, Maryland, Michigan, New Hampshire, Ohio, Oregon, Virginia and Washington. Like Rite Aid's ex

Rite Aid Expands No-Charge COVID-19 Testing to All Drive-Through Locations

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is expanding its no-charge COVID-19 testing capabilities with 317 additional drive-through testing site locations opening across New Jersey, New York and Pennsylvania on Friday, February 5, through its partnership with the U.S. Department of Health and Human Services (HHS). Like Rite Aid's existing testing sites, the new locations will utilize PCR, simple self-swab nasal tests overseen by Rite Aid pharmacists. Each site will operate Monday t

Rite Aid Opens More Than 300 New No-Charge COVID-19 Testing Sites

Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?

Is Rite Aid (RAD) Stock Outpacing Its Retail-Wholesale Peers This Year?

Dick's Sporting Goods

Lowe's

Michaels

Target

Americans feel a bit confident now about the labor market and the overall economic environment. Michaels (MIK), Rite Aid (RAD), DICK'S Sporting (DKS), Target (TGT) and Lowe's (LOW) will be a great addition to your portfolio.

5 Retail Stocks in Focus as Americans Look Confident Now

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19 testing capabilities with 60 additional drive-through locations opening on Friday, January 22, through its partnership with the U.S. Department of Health and Human Services (HHS). Additionally, no-charge testing will now be available for ages four and older at all new and existing drive-through testing sites. Previously, testing had been available to individuals 13 years of age and older. The new l

Rite Aid Expands No-Charge COVID-19 Testing to 460 Drive-Through Locations

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Down 9.1% Since Last Earnings Report: Can It Rebound?

Rite Aid Corporation (RAD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Rite Aid (RAD)

Rite Aid (RAD) remains poised for solid growth ahead, driven by strength in online services, PBM market and Elixir.

Here's Why Rite Aid (RAD) Marching Ahead of the Industry

Rite Aid Corporation (RAD) CEO Heyward Donigan Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)

Rite Aid has given more than 5,000 Covid vaccations so far and it's seen the rollout's challenges firsthand, its CEO said.

Rite Aid CEO said retailers will get tapped sooner than expected to help speed vaccine rollout

CVS Health

Walgreens

The three drugstore chains have expanded their digital offerings and stepped up their focus on health and wellness to keep up with consumer preferences.

Covid vaccinations offer CVS, Walgreens and Rite Aid a chance to showcase how drugstores have changed

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) announced today that Heyward Donigan, president and chief executive officer; Jim Peters, chief operating officer and Matt Schroeder, executive vice president and chief financial officer will participate in a fireside chat with investors at the 39th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11th at approximately 11:40 a.m. ET. The conference is a virtual event. The appearance will be broadcast via the Internet at ht

Rite Aid to Present at the 39th Annual J.P. Morgan Healthcare Conference

American Airlines

Continental Resources

Stitch Fix

Virgin Galactic

SunPower

Bed Bath & Beyond

Short squeezes can fuel massive rallies in just a couple of days, making these some of the best stocks to buy when timed correctly. The post 7 Best Stocks to Buy for a Potential Short Squeeze appeared first on InvestorPlace.

7 Best Stocks to Buy for a Potential Short Squeeze

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

News for Rite Aid Stock (RAD)